Nucleophosmin-Anaplastic Lymphoma Kinase of Large-Cell Anaplastic Lymphoma Is a Constitutively Active Tyrosine Kinase That Utilizes Phospholipase C-γ To Mediate Its Mitogenicity

REFERENCES

• Alimandi, M., M. A. Heidaran, J. S. Gutkind, J. Zhang, N. Ellmore, M. Valius, A. Kazlauskas, J. H. Pierce, and W. Li 1997. PLC-gamma activation is required for PDGF-betaR-mediated mitogenesis and monocytic differentiation of myeloid progenitor cells. Oncogene 15: 585–593.
   PubMed Web of Science ®Google Scholar
• Atherton, E., and R. C. Sheppard 1989. Solid phase peptide synthesis—a practical approach. IRL Press, Oxford, England.
   Google Scholar
• Bartram, C. R., A. de Klein, A. Hagemeijer, T. van Agthoven, A. D. van Kessel, D. Bootsma, G. Grosveld, M. A. Ferguson-Smith, T. Davies, M. Stone, N. Heisterkamp, J. R. Stephenson, and J. Groffen 1983. Translocation of c-Abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukemia. Nature 306: 277–280.
   PubMed Web of Science ®Google Scholar
• Bischof, D., K. Pulford, D. Y. Mason, and S. W. Morris 1997. Role of the nucleophosmin (NPM) portion of the non-Hodgkin’s lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol. Cell. Biol. 17: 2312–2325.
   PubMed Web of Science ®Google Scholar
• Borer, R. A., C. F. Lehner, H. M. Eppenberger, and E. A. Nigg 1989. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56: 379–390.
   PubMed Web of Science ®Google Scholar
• Chan, W. Y., Q. R. Liu, J. Borjigin, H. Busch, O. M. Rennert, L. A. Tease, and P. K. Chan 1989. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28: 1033–1039.
   PubMed Web of Science ®Google Scholar
• Cortez, D., L. Kadlec, and A. M. Pendergast 1995. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol. Cell. Biol. 15: 5531–5541.
   PubMed Web of Science ®Google Scholar
• Daly, R. J., G. M. Sanderson, P. W. Janes, and R. L. Sutherland 1996. Cloning and characterization of GRB14, a novel member of the GRB7 gene family. J. Biol. Chem. 271: 12502–12510.
   PubMedGoogle Scholar
• Dieter, P., S. A. Schulze, and E. Fitzke 1991. Activation of phospholipase C is not correlated to the formation of prostaglandins and superoxide in cultured rat liver macrophages. Cell. Signalling 3: 65–71.
   PubMedGoogle Scholar
• Dumbar, T. S., G. A. Gentry, and M. O. Olson 1989. Interaction of nucleolar phosphoprotein B23 with nucleic acids. Biochemistry 28: 9495–9501.
   PubMed Web of Science ®Google Scholar
• Duyster, J., R. Baskaran, and J. Y. J. Wang 1995. Catalytic role for the SH2 domain of Abl tyrosine kinase. Proc. Natl. Acad. Sci. USA 92: 1555–1559.
   PubMed Web of Science ®Google Scholar
• Fujimoto, J., M. Shiota, T. Iwahara, N. Seki, H. Satoh, S. Mori, and T. Yamamoto 1996. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc. Natl. Acad. Sci. USA 93: 4181–4186.
   PubMed Web of Science ®Google Scholar
• Goga, A., J. McLaughlin, D. E. Afar, D. C. Saffran, and O. N. Witte 1995. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. Cell 82: 981–988.
   PubMed Web of Science ®Google Scholar
• Hall, H., E. J. Williams, S. E. Moore, F. S. Walsh, A. Prochiantz, and P. Doherty 1996. Inhibition of FGF-stimulated phosphatidylinositol hydrolysis and neurite outgrowth by a cell-membrane permeable phosphopeptide. Curr. Biol. 6: 580–587.
   PubMedGoogle Scholar
• Heisterkamp, N., J. R. Stephenson, J. Groffen, P. F. Hansen, A. de Klein, C. R. Bartram, and G. Grosveld 1983. Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 315: 758–761.
   Google Scholar
• Iwahara, T., J. Fujimoto, D. Wen, R. Cupples, N. Bucay, T. Arakawa, S. Mori, B. Ratzkin, and T. Yamamoto 1997. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene 14: 439–449.
   PubMed Web of Science ®Google Scholar
• Kadin, M. E. 1994. Ki-1/CD30+ (anaplastic) large-cell lymphoma: maturation of a clinicopathologic entity with prospects of effective therapy. J. Clin. Oncol. 12: 884–887.
   PubMed Web of Science ®Google Scholar
• Kashishian, A., and J. A. Cooper 1993. Phosphorylation sites at the C-terminus of the platelet-derived growth factor receptor bind phospholipase C gamma 1. Mol. Biol. Cell 4: 49–57.
   PubMedGoogle Scholar
• Katan, M. 1996. The control of inositol lipid hydrolysis. Cancer Surv. 27: 199–211.
   PubMedGoogle Scholar
• Kim, H. K., J. W. Kim, A. Zilberstein, B. Margolis, J. G. Kim, J. Schlessinger, and S. G. Rhee 1991. PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation on tyrosine residues 783 and 1254. Cell 65: 435–441.
   PubMed Web of Science ®Google Scholar
• Koch, C. A., D. Anderson, M. F. Moran, C. Ellis, and T. Pawson 1991. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252: 668–674.
   PubMed Web of Science ®Google Scholar
• Kozutsumi, H., H. Toyoshima, K. Hagiwara, Y. Yazaki, and H. Hirai 1994. Human ltk receptor tyrosine kinase binds to PLC-gamma 1, PI3-K, GAP and Raf-1 in vivo. Oncogene 9: 2991–2998.
   PubMedGoogle Scholar
• Kuefer, M. U., A. T. Look, K. Pulford, F. G. Behm, P. K. Pattengale, D. Y. Mason, and S. W. Morris 1997. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 90: 2901–2910.
   PubMed Web of Science ®Google Scholar
• Mason, D. Y., C. Bastard, R. Rimokh, N. Dastugue, J. L. Huret, U. Kristoffersson, J. P. Magaud, C. Nezelof, H. Tilly, and J. P. Vannier 1990. CD30-positive large-cell lymphomas (‘Ki-1 lymphoma’) are associated with a chromosomal translocation involving 5q35. Br. J. Haematol. 74: 161–168.
   PubMed Web of Science ®Google Scholar
• McWhirter, J. R., and J. Y. J. Wang 1993. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12: 1533–1546.
   PubMed Web of Science ®Google Scholar
• Mes-Masson, A. M., J. McLaughlin, G. Q. Daley, M. Paskind, and O. N. Witte 1986. Overlapping cDNA clones define the complete coding region for the p210 Bcr-Abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc. Natl. Acad. Sci. USA 83: 9768–9772.
   PubMed Web of Science ®Google Scholar
• Morris, S. W., M. N. Kirstein, M. B. Valentine, K. G. Dittmer, D. N. Shapiro, D. L. Saltman, and A. T. Look 1994. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science 263: 1281–1284.
   PubMed Web of Science ®Google Scholar
• Morris, S. W., C. Naeve, P. Mathew, P. L. James, M. N. Kirstein, X. Cui, and D. P. Witte 1997. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin’s lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 14: 2175–2188.
   PubMed Web of Science ®Google Scholar
• Noh, D. Y., S. H. Shin, and S. G. Rhee 1995. Phosphoinositide-specific phospholipase C and mitogenic signaling. Biochim. Biophys. Acta 1242: 99–113.
   PubMed Web of Science ®Google Scholar
• Obermeier, A., R. A. Bradshaw, K. Seedorf, A. Choidas, J. Schlessinger, and A. Ullrich 1994. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma. EMBO J. 13: 1585–1590.
   PubMed Web of Science ®Google Scholar
• Ohta, S., A. Matsui, Y. Nazawa, and Y. Kagawa 1988. Complete cDNA encoding a putative phospholipase C from transformed human lymphocytes. FEBS Lett. 242: 31–35.
   PubMedGoogle Scholar
• Ooi, J., V. Yajnik, D. Immanuel, M. Gordon, J. J. Moskow, A. M. Buchberg, and B. Margolis 1995. The cloning of Grb10 reveals a new family of SH2 domains proteins. Oncogene 10: 1621–1630.
   PubMedGoogle Scholar
• Palacios, R., and M. Steinmetz 1985. IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41: 727–734.
   PubMed Web of Science ®Google Scholar
• Pascal, S. M., A. U. Singer, G. Gish, T. Yamazaki, S. E. Shoelson, T. Pawson, L. E. Kay, and K. J. Forman 1994. Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide. Cell 77: 461–472.
   PubMedGoogle Scholar
• Pawson, T. 1995. Protein modules and signalling networks. Nature 373: 573–580.
   PubMed Web of Science ®Google Scholar
• Renshaw, M. W., J. R. McWhirter, and J. Y. J. Wang 1995. The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol. Cell. Biol. 15: 1286–1293.
   PubMed Web of Science ®Google Scholar
• Rodrigues, G. A., and M. Park 1994. Oncogenic activation of tyrosine kinases. Curr. Opin. Genet. Dev. 4: 15–24.
   PubMedGoogle Scholar
• Rotin, D., B. Margolis, M. Mohammadi, R. J. Daly, G. Daum, N. Li, E. H. Fischer, W. H. Burgess, A. Ullrich, and J. Schlessinger 1992. SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma. EMBO J. 11: 559–567.
   PubMedGoogle Scholar
• Sawyers, C. L., and C. T. Denny 1994. Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about. Cell 77: 171–173.
   PubMed Web of Science ®Google Scholar
• Sawyers, C. L., J. McLaughlin, and O. N. Witte 1995. Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J. Exp. Med. 181: 307–313.
   PubMed Web of Science ®Google Scholar
• Schmidt, Z. M., and W. W. Franke 1988. DNA cloning and amino acid sequence determination of a major constituent protein of mammalian nucleoli. Correspondence of the nucleoplasmin-related protein NO38 to mammalian protein B23. Chromosoma 96: 417–426.
   PubMedGoogle Scholar
• Shiota, M., J. Fujimoto, T. Semba, H. Satoh, T. Yamamoto, and S. Mori 1994. Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line AMS3. Oncogene 9: 1567–1574.
   PubMed Web of Science ®Google Scholar
• Smith, D. B., and K. S. Johnson 1988. Single-step purification of polypeptide expressed in Escherichia coli as fusions with glutathione- S -transferase. Gene 67: 31–40.
   PubMed Web of Science ®Google Scholar
• Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. Cantley 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72: 767–778.
   PubMed Web of Science ®Google Scholar
• Stein, H., and F. Dallenbach 1992. Neoplastic hematopathology 675–714Williams & Wilkins, Baltimore, Md.
   Google Scholar
• Stein, H., H. Herbst, I. Anagnostopoulos, G. Niedobitek, F. Dallenbach, and H. C. Kratzsch 1991. The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma. Ann. Oncol. 2: 33–38.
   PubMed Web of Science ®Google Scholar
• Ueno, H., K. Sasaki, H. Kozutsumi, K. Miyagawa, K. Mitani, Y. Yazaki, and H. Hirai 1996. Growth and survival signals transmitted via two distinct NPXY motifs within leukocyte tyrosine kinase, an insulin receptor-related tyrosine kinase. J. Biol. Chem. 271: 27707–27714.
   PubMedGoogle Scholar
• Ullrich, A., and J. Schlessinger 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203–212.
   PubMed Web of Science ®Google Scholar
• Valius, M., C. Bazenet, and A. Kazlauskas 1993. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor β subunit and are required for binding of phospholipase Cγ and a 64-kilodalton protein, respectively. Mol. Cell. Biol. 13: 133–143.
   PubMedGoogle Scholar